Abaxis (Nasdaq: ABAX) reported earnings on July 25. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q1), Abaxis whiffed on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue expanded slightly. GAAP earnings per share grew.

Gross margins dropped, operating margins dropped, net margins grew.

Revenue details
 Abaxis recorded revenue of $43.2 million. The seven analysts polled by S&P Capital IQ wanted to see revenue of $48.9 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.14. The eight earnings estimates compiled by S&P Capital IQ predicted $0.23 per share. GAAP EPS of $0.14 for Q1 were 7.7% higher than the prior-year quarter's $0.13 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 48.4%, 600 basis points worse than the prior-year quarter. Operating margin was 10.7%, 70 basis points worse than the prior-year quarter. Net margin was 7.5%, 70 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $48.1 million. On the bottom line, the average EPS estimate is $0.20.

Next year's average estimate for revenue is $195.8 million. The average EPS estimate is $0.92.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 163 members out of 179 rating the stock outperform, and 16 members rating it underperform. Among 47 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 43 give Abaxis a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Abaxis is hold, with an average price target of $45.71.

Is Abaxis the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.